576 research outputs found
Template-assisted colloidal self-assembly of macroscopic magnetic metasurfaces
We demonstrate a template-assisted colloidal self-assembly approach for magnetic metasurfaces on macroscopic areas. The choice of anisotropic colloidal particle geometry, assembly pattern and metallic film is based on rational design criteria, taking advantage of mirror-charge effects for gold nanorods placed on gold film. Monodisperse gold nanorods prepared utilizing wet-chemistry are arranged with high precision on wrinkled templates to form linear array-type assemblies and subsequently transferred to a thin gold film. Due to the obtained particle-to-film distance of 1.1 nm, the plasmonic mode of the nanorod is able to couple efficiently with the supporting metallic film, giving rise to a magnetic mode in the visible spectrum (721 nm). Conventional UV-vis-NIR measurements in close correlation with electromagnetic simulations provide evidence for the presence of a magnetic resonance on the macroscopic area. The herein presented scalable lithography-free fabrication process paves the road towards colloidal functional metasurfaces with an optical response in the effective magnetic permeability
Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding
Macrophage infectivity potentiator (MIP) proteins are widespread in human pathogens including Legionella pneumophila, the causative agent of Legionnaires' disease and protozoans such as Trypanosoma cruzi. All MIP proteins contain a FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain that hence presents an attractive drug target. Some MIPs such as the Legionella pneumophila protein (LpMIP) have additional appendage domains of mostly unknown function. In full-length, homodimeric LpMIP, the N-terminal dimerization domain is linked to the FKBP-like domain via a long, free-standing stalk helix. Combining X-ray crystallography, NMR and EPR spectroscopy and SAXS, we elucidated the importance of the stalk helix for protein dynamics and inhibitor binding to the FKBP-like domain and bidirectional crosstalk between the different protein regions. The first comparison of a microbial MIP and a human FKBP in complex with the same synthetic inhibitor was made possible by high-resolution structures of LpMIP with a [4.3.1]-aza-bicyclic sulfonamide and provides a basis for designing pathogen-selective inhibitors. Through stereospecific methylation, the affinity of inhibitors to L. pneumophila and T. cruzi MIP was greatly improved. The resulting X-ray inhibitor-complex structures of LpMIP and TcMIP at 1.49 and 1.34 Ă
, respectively, provide a starting point for developing potent inhibitors against MIPs from multiple pathogenic microorganisms
Liquid Cooling of Bright LEDs for Automotive Applications
With the advances in the technology of materials based on GaN, high brightness white light emitting diodes (LEDs) have flourished over the past few years and have shown to be very promising in many new illumination applications such as outdoor illumination, task and decorative lighting as well as aircraft and automobile illuminations. The objective of this paper is to investigate an active liquid cooling solution of such LEDs in an application of automotive headlights. The thermal design from device to board to system level has been carried out in this research. Air cooling and passive liquid cooling methods are investigated and excluded as unsuitable, and therefore an active liquid cooling solution is selected. Several configurations of the active liquid cooling system are studied and optimisation work has been carried out to find an optimum thermal performance
Legionella pneumophila macrophage infectivity potentiator protein appendage domains modulate protein dynamics and inhibitor binding
Macrophage infectivity potentiator (MIP) proteins are widespread in human pathogens including Legionella pneumophila, the causative agent of Legionnaires' disease and protozoans such as Trypanosoma cruzi. All MIP proteins contain a FKBP (FK506 binding protein)-like prolyl-cis/trans-isomerase domain that hence presents an attractive drug target. Some MIPs such as the Legionella pneumophila protein (LpMIP) have additional appendage domains of mostly unknown function. In full-length, homodimeric LpMIP, the N-terminal dimerization domain is linked to the FKBP-like domain via a long, free-standing stalk helix. Combining X-ray crystallography, NMR and EPR spectroscopy and SAXS, we elucidated the importance of the stalk helix for protein dynamics and inhibitor binding to the FKBP-like domain and bidirectional crosstalk between the different protein regions. The first comparison of a microbial MIP and a human FKBP in complex with the same synthetic inhibitor was made possible by high-resolution structures of LpMIP with a [4.3.1]-aza-bicyclic sulfonamide and provides a basis for designing pathogen-selective inhibitors. Through stereospecific methylation, the affinity of inhibitors to L. pneumophila and T. cruzi MIP was greatly improved. The resulting X-ray inhibitor-complex structures of LpMIP and TcMIP at 1.49 and 1.34âŻĂ
, respectively, provide a starting point for developing potent inhibitors against MIPs from multiple pathogenic microorganisms.</p
Belowground DNA-based techniques: untangling the network of plant root interactions
Contains fulltext :
91591.pdf (publisher's version ) (Closed access)7 p
Assessment of genetically modified maize\ua04114 for food and feed uses, under Regulation (EC) No\ua01829/2003 (application EFSA-GMO-NL-2014-123)
Maize\ua04114 was developed through Agrobacterium\ua0tumefaciens-mediated transformation to provide protection against certain lepidopteran and coleopteran pests by expression of the Cry1F, Cry34Ab1 and Cry35Ab1 proteins derived from Bacillus\ua0thuringiensis, and tolerance to the herbicidal active ingredient glufosinate-ammonium by expression of the PAT protein derived from Streptomyces viridochromogenes. The molecular characterisation data did not identify issues requiring assessment for food/feed safety. None of the compositional, agronomic and phenotypic differences identified between maize\ua04114 and the non-genetically modified (GM) comparator(s) required further assessment. There were no concerns regarding the potential toxicity and allergenicity of the newly expressed proteins Cry1F, Cry34Ab1, Cry35Ab1 and PAT, and no evidence that the genetic modification might significantly change the overall allergenicity of maize 4114. The nutritional value of food/feed derived from maize 4114 is not expected to differ from that derived from non-GM maize varieties and no post-market monitoring of food/feed is considered necessary. In the case of accidental release of viable maize\ua04114 grains into the environment, maize\ua04114 would not raise environmental safety concerns. The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of maize\ua04114. The genetically modified organism (GMO) Panel\ua0concludes that maize\ua04114 is as safe as the non-GM comparator(s) and non-GM reference varieties with respect to potential effects on human and animal health and the environment in the context of the scope of this application
Guidance on allergenicity assessment of genetically modified plants
This document provides supplementary guidance on specific topics for the allergenicity risk assessment of genetically modified plants. In particular, it supplements general recommendations outlined in previous EFSA GMO Panel guidelines and Implementing Regulation (EU) No 503/2013. The topics addressed are non-IgE-mediated adverse immune reactions to foods, in vitro protein digestibility tests and endogenous allergenicity. New scientific and regulatory developments regarding these three topics are described in this document. Considerations on the practical implementation of those developments in the risk assessment of genetically modified plants are discussed and recommended, where appropriate. (C) 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority
- âŠ